These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8390101)

  • 1. Blood donor screening for hepatitis C.
    Dusheiko GM
    S Afr Med J; 1993 Mar; 83(3):217-8. PubMed ID: 8390101
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-hepatitis C antibody screening at the Natal Blood Transfusion Service.
    Soni PN; Robson SC; Kirsch RE; Simjee AE
    S Afr Med J; 1993 Mar; 83(3):218. PubMed ID: 8390102
    [No Abstract]   [Full Text] [Related]  

  • 3. [Post-transfusional hepatitis].
    González A; Esteban JI
    Sangre (Barc); 1993 Jun; 38(3):193-200. PubMed ID: 7692610
    [No Abstract]   [Full Text] [Related]  

  • 4. [Post-transfusion hepatitis C in Finland].
    Ebeling F
    Duodecim; 1993; 109(8):709. PubMed ID: 7520387
    [No Abstract]   [Full Text] [Related]  

  • 5. [Seroprevalence of hepatitis C antiviral antibodies in blood donors in N'Djamena (Chad)].
    Massenet D; Djime O
    Bull Soc Pathol Exot; 1993; 86(4):235. PubMed ID: 7507370
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays.
    Aach RD; Stevens CE; Hollinger FB; Mosley JW; Peterson DA; Taylor PE; Johnson RG; Barbosa LH; Nemo GJ
    N Engl J Med; 1991 Nov; 325(19):1325-9. PubMed ID: 1656258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155
    [No Abstract]   [Full Text] [Related]  

  • 9. Viral hepatitis in Nigeria--sickle-cell disease and commercial blood donors.
    Mutimer DJ; Olomu A; Skidmore S; Olomu N; Ratcliffe D; Rodgers B; Mutimer HP; Gunson BK; Elias E
    QJM; 1994 Jul; 87(7):407-11. PubMed ID: 7922292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C infection in liver transplant patients.
    McCaughan GW; Pau A; Parsons C; McGuinness PH; Gallagher ND; Sheil AG
    Transplant Proc; 1992 Oct; 24(5):2256. PubMed ID: 1384207
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
    Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
    Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pattern of non-A, non-B hepatitis is more and more evident. A new test for diagnosis of hepatitis C makes it possible to mass screen blood donors].
    Iwarson S
    Lakartidningen; 1990 Jan; 87(1-2):13-4. PubMed ID: 2105416
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody to hepatitis C virus in volunteer blood donors of the Hospital de Especialidades, National Medical Center, Mexico City.
    Islas S; Yamaguchi K; Nishimura Y; Kawano F; Revilla MC; Takatsuki K
    Arch Med Res; 1994; 25(3):361-2. PubMed ID: 7528583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus in Pune, India.
    Arankalle A; Chobe P; Banerjee K
    J Assoc Physicians India; 1992 Aug; 40(8):562-3. PubMed ID: 1284987
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low cost anti-HCV screening of blood donors.
    Neill AG; Conradie JD
    Lancet; 1992 Oct; 340(8827):1096. PubMed ID: 1357481
    [No Abstract]   [Full Text] [Related]  

  • 19. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
    Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H;
    Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to hepatitis C virus and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction.
    Zhang YY; Guo LS; Hao LJ; Hansson BG; Widell A; Nordenfelt E
    Chin Med J (Engl); 1993 Mar; 106(3):171-4. PubMed ID: 7686839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.